New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
12:55 EDTAET, AET, WCG, WCG, WAG, WAG, UNH, UNH, UAM, UAM, MOH, MOH, MGLN, MGLN, HUM, HUM, HNT, HNT, ESRX, ESRX, CVS, CVS, CTRX, CTRX, CNC, CNC, CI, CI, WLP, WLPLeerink healthcare services analyst holds an analyst/industry conference call
Healthcare Services Analyst Gupte discusses the ongoing wave of specialty pharmaceuticals innovation and the implications for health plans and pharmacy benefit management on an Analyst/Industry conference call. Relevant companies AET, CI, CNC, CTRX, CVS, ESRX, HNT, HUM, MGLN, MOH, UAM, UNH, WAG, WCG and WLP may be discussed on the Analyst/Industry conference call to be held on May 30 at 1:30 pm.
News For AET;CI;CNC;CTRX;CVS;ESRX;HNT;HUM;MGLN;MOH;UAM;UNH;WAG;WCG;WLP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 8, 2015
10:01 EDTCTRXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Almost Family (AFAM) downgraded to Neutral from Outperform at Baird... Angie's List (ANGI) downgraded to Neutral from Buy at B. Riley... Annaly Capital (NLY) downgraded to Underperform from Market Perform at FBR Capital... Apple (AAPL) downgraded to Hold from Buy at Societe Generale... Calamos (CLMS) downgraded to Underperform from Market Perform at Keefe Bruyette... Catamaran (CTRX) downgraded to Hold from Buy at Argus... Cinemark (CNK) downgraded to Neutral from Buy at Janney Capital... Crestwood Equity (CEQP) downgraded at BofA/Merrill... Cummins (CMI) downgraded to Neutral from Buy at Goldman... Kinder Morgan (KMI) downgraded to Buy from Conviction Buy at Goldman... L'Oreal (LRLCY) downgraded to Neutral from Outperform at Exane BNP Paribas... NextEra Energy Partners (NEP) downgraded to Neutral from Buy at Goldman... Regal Entertainment (RGC) downgraded to Neutral from Buy at Janney Capital... Trina Solar (TSL) downgraded at BofA/Merrill... WebMD (WBMD) downgraded to Sell from Neutral at Goldman... Yingli Green Energy (YGE) downgraded at BofA/Merrill... Zep Inc. (ZEP) downgraded to Sell from Buy at Wunderlich.
07:31 EDTCTRXCatamaran downgraded to Hold from Buy at Argus
Subscribe for More Information
April 7, 2015
10:23 EDTCI, HUM, UNH, AET, MGLNMedicare Advantage 2016 rates set above expectations
The U.S. yesterday announced higher than expected 2016 Medicare Advantage reimbursement rates. The news is seen as benefiting managed care companies with large exposure to the Medicare Advantage program. WHAT'S NEW: The Centers for Medicare and Medicaid Services, or CMS, yesterday afternoon announced that Medicare Advantage reimbursement rates would rise 1.25% in 2016 from 2015 levels. In February, CMS proposed a 0.95% reduction in Medicare Advantage reimbursement rates for 2016. This year, reimbursement rates have fallen 4%. WHAT'S NOTABLE: Humana (HUM) said this morning in a regulatory filing that based on its review of the Final Rate Notice, the company expects an average Medicare Advantage funding increase for its business of approximately 0.8% from CMS for 2016, versus a funding decline of 1.25%-1.75% previously expected based on the Advance Notice. Humana’s estimated year-over-year funding increase as it affects the company is projected to be less than the CMS estimate for the MA program primarily due to Humana’s view of the projected impact associated with CMS’ 2016 adjustment to the risk model calculation, the company explained. ANALYST REACTION: In a note to investors earlier today, Deutsche Bank analyst Scott Fidel wrote that this is the first time in seven years that CMS has implemented an increase in Medicare Advantage rates. However, noting that CMS said it had raised its estimates for Medicare costs, Fidel added that this forecast tempered the positive outlook created by the reimbursement increase. The analyst kept Buy ratings on the following stocks in the sector: Aetna (AET), Anthem (ANTM), Cigna (CI), Magellan Health (MGLN), and UnitedHealth (UNH). Stifel analysts said that the results were modestly better than expected, except for the agency's decision not to make a Star rating adjustment for plans with certain higher acuity populations. The firm thinks that more diversified managed care companies with Medicare Advantage products could be boosted by CMS' decision, identifying Aetna, Humana, and UnitedHealth as being among the companies in that category. PRICE ACTION: In early trading, Aetna was little changed at $107.40, Anthem was flat near $155 per share, Cigna slipped 0.4% to $131.34, Magellan was flat at $71, UnitedHealth added 0.5% to $118.31 and Humana gained fractionally to $178.54.
10:05 EDTCTRXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:57 EDTHUMHumana sees average Medicare Advantage funding from CMS up 0.8% for 2016
Humana noted that on Monday, April 6, after the market close, the Centers for Medicare and Medicaid Services, or CMS, announced final 2016 Medicare benchmark payment rates and related technical factors impacting the bid benchmark premiums, as expected, following the February 20 release of the preliminary 2016 Medicare Advantage benchmark payment rates. Humana said in its regulatory filing that based on its review of the Final Rate Notice, Humana expects an average Medicare Advantage funding increase for its business of approximately 0.8% from CMS for 2016, versus a funding decline of 1.25%-1.75% previously expected based on the Advance Notice. The Final Rate Notice from CMS estimates an average funding increase of 1.25% for the MA program, versus its estimate of a funding decline of 0.95% per the Advance Notice. Humana’s estimated year-over-year funding increase as it affects the company is projected to be less than the CMS estimate for the MA program primarily due to Humana’s view of the projected impact associated with CMS’ 2016 adjustment to the risk model calculation. The company is completing more detailed analyses of the Final Rate Notice and the commensurate impacts on its 2016 Medicare benefit offerings, including geographic-specific impacts, and anticipates further discussion in its Q1 earnings call on April 29. Bid designs for the company’s 2016 Medicare Advantage offerings are due to CMS on June 1, the company noted.
08:29 EDTCTRXCatamaran downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
08:20 EDTHUM, AET, CI, WCG, HNTCowen expects managed care stocks to outperform following CMS release
Cowen expects managed care stocks to outperform today following the CMS release outlining better than expected Medicare Advantage rates for 2016. The firm also sees improved FFS growth rates, maintained coding intensity adjustment, and continued HRA payments. Publicly traded companies in the space include Aetna (AET), Cigna (CI), Health Net (HNT), Humana (HUM), and WellCare (WCG).
07:57 EDTCI, UNH, WCG, HUMManaged care companies likely to rise on CMS news, says Oppenheimer
Subscribe for More Information
07:44 EDTAET, UNH, HUMSome managed care stocks could be boosted by CMS decision, says Stifel
Subscribe for More Information
07:41 EDTUNH, CI, HNT, HUM, WCG, AET2016 MA rates positive for first time in seven years, says Deutsche Bank
Deutsche Bank notes that for the first time since 2009, Medicare Advantage rates will be positive after the Centers for Medicare and Medicaid Services announced yesterday that final 2016 rates will rise by 1.25%, representing a 220 basis points favorable swing from the preliminary proposed cut of 0.95%. Deutsche says the positive surprise is "somewhat tempered" by the more cautious view on Medicare cost trends provided by the CMS actuaries in the final 2016 rate announcement. The firm expects Humana (HUM), Health Net (HNT) and UnitedHealth (UNH), Aetna (AET) and Anthem (ANTM) to experience Medicare Advantage rate increases.
07:39 EDTWCG, HNT, MOHSome managed care stocks could be pressured by CMS decision, says Stifel
Subscribe for More Information
06:56 EDTAETAetna CEO sees 'groundswell' of wage increases in coming months, WSJ reports
Mark Bertolini, the CEO of Aetna, says he believes there will be a "groundswell" of pay increases for the lowest-paid employees at big companies in the next few months, The Wall Street Journal reports. Bertolini commented at a Peterson Institute for International Economics event that he believes "there are a number of CEOs that will come out in the next six months with wage increases that will matter." Reference Link
06:08 EDTCVSNew York REIT announces 22,00 square foot lease with CVS at 1440 Broadway
New York REIT (NYRT) announced that is has completed a long-term lease totaling approximately 22,000 square feet with CVS/pharmacy (CVS) at 1440 Broadway. The deal marks the first step in NYRT's overall retail repositioning strategy at 1440 Broadway, with remaining value-add opportunities to mark existing below-market tenant rents to market and to re-configure a portion of the basement into valuable, lower-level selling space with double ceiling-heights.
05:48 EDTCTRX, UNHCatamaran downgraded to Hold from Buy at Jefferies
Subscribe for More Information
April 6, 2015
13:12 EDTCTRX, UNHCatamaran purchase expected to clear antitrust hurdles, CT Financial News says
Optum, a unit of UnitedHealth (UNH), is expected to face close scrutiny by regulators over its proposed acquisition of Catamaran (CTRX) and its pharmacy benefits management unit, but the deal is likely to be approved by regulators, CT Financial News reports, adding that the prospective deal could start a wave of consolidation among PBMs. Norm Smith, president and founder of health care research firm Viewpoint Consulting, believes the ultimate beneficiaries of the OptumRx/Catamaran deal will be consumers and health insurers. Reference Link
11:11 EDTCTRXOptions with decreasing implied volatility
Options with decreasing implied volatility: BDSI CONN HLSS CTRX DANG ARCP KMX MAC
10:02 EDTCTRXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AGCO (AGCO) downgraded to Sell from Hold at Deutsche Bank... CONSOL (CNX) downgraded to Hold from Buy at Deutsche Bank... Catamaran (CTRX) downgraded to Market Perform from Outperform at BMO Capital... Comerica (CMA) downgraded to Neutral from Buy at Guggenheim... Gannett (GCI) downgraded to Market Perform from Outperform at FBR Capital... Magnum Hunter (MHR) downgraded to Hold from Buy at Wunderlich... Qualcomm (QCOM) downgraded to Market Perform from Outperform at FBR Capital... Regions Financial (RF) downgraded to Neutral from Buy at Guggenheim... SAP (SAP) downgraded at Wells Fargo... Sanderson Farms (SAFM) downgraded to Underweight from Sector Weight at KeyBanc... Scorpio Tankers (STNG) downgraded to Neutral from Accumulate at Global Hunter... Simpson Manufacturing (SSD) downgraded to Neutral from Buy at DA Davidson... Skyworks (SWKS) downgraded at Stephens... TripAdvisor (TRIP) downgraded to Hold from Buy at Needham... Western Union (WU) downgraded to Neutral from Positive at Susquehanna... Zillow Group (Z) downgraded to Equal Weight from Overweight at Barclays.
08:57 EDTCTRXCatamaran downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information
07:57 EDTHNT, CI, CNC, CTRX, AET, WCG, MOH, HUM, ESRX, UNH, MGLNLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Gupte discusses the leverage Anthem likely has in its Pharmacy Benefit Manager (PBM) contract with Express Scripts and how it changes after the Catamaran-Optum Rx deal, the synergy potential for the deal between Catamaran and Optum Rx and the likelihood of Cigna-HS remaining with the newly merged Optum Rx-CTRX on an Analyst/Industry conference call to be held on April 6 at 2 pm.
April 5, 2015
09:06 EDTUNHUnitedHealth looks expensive, Barron's says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use